C3-R Corneal Collagen Crosslinking with Riboflavin for Keratoconus

In development overseas for over 10 years, corneal crosslinking is now approved by the FDA for use in our country. Patients with keratoconus, a progressive thinning, warping and scarring of the cornea related in part to chronic eye rubbing, may now benefit from crosslinking to stabilize their corneal structure and decrease the need for corneal transplantation.

Dr. Clark is trained in Avedro’s Photrexa® Viscous, Photrexa® and KXL® System.